Literature DB >> 512027

Immunoblastic lymphadenopathy: evolution into immunoblastic sarcoma.

S Banik, R L Ward, P S Hasleton.   

Abstract

A case of immunoblastic lymphadenopathy which underwent transformation into immunoblastic sarcoma is reported. A 64-year-old man presented with a rash, generalised lymphadenopathy, and hepatosplenomegaly. A cervical lymph node removed at biopsy showed the features of immunoblastic lymphadenopathy with the presence of heavy chain classes IgG, IgM, and IgA and both kappa and lambda light chain types in the cytoplasm of the immunoblasts. No such immunoglobulins could be demonstrated in the lymph nodes obtained at necropsy when the patient died of widespread immunoblastic sarcoma. The biological evolution and histogenesis of the disease are discussed and the current literature is reviewed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 512027      PMCID: PMC1145909          DOI: 10.1136/jcp.32.11.1110

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  24 in total

1.  Immunoglobulin in Reed-Sternberg and Hodgkin cells.

Authors:  R C Curran; E L Jones
Journal:  J Pathol       Date:  1978-09       Impact factor: 7.996

2.  "Immunoblasts" and "immunocytes"--an attempt at a functional nomenclature.

Authors:  W DAMESHEK
Journal:  Blood       Date:  1963-02       Impact factor: 22.113

3.  Immunoblastic lymphadenopathy. A mixed proliferation of T and B lymphocytes.

Authors:  R A Rudders; R DeLellis
Journal:  Am J Clin Pathol       Date:  1977-10       Impact factor: 2.493

4.  Immunoblastic lymphadenopathy. A report of two cases.

Authors:  J I Spector; S Miller
Journal:  JAMA       Date:  1977-09-19       Impact factor: 56.272

5.  Angioimmunoblastic lymphadenopathy: an ultrastructural and immunologic study with review of the literature.

Authors:  R S Neiman; P Dervan; C Haudenschild; R Jaffe
Journal:  Cancer       Date:  1978-02       Impact factor: 6.860

6.  Amyloid deposition in immunoblastic lymphadenopathy.

Authors:  J A Madri; F Fromowitz
Journal:  Hum Pathol       Date:  1978-03       Impact factor: 3.466

7.  Malignant lymphoma arising in angioimmunoblastic lymphadenopathy.

Authors:  B N Nathwani; H Rappaport; E M Moran; G A Pangalis; H Kim
Journal:  Cancer       Date:  1978-02       Impact factor: 6.860

8.  Prednisone in treatment of allergen-associated angio-immunoblastic lymphadenopathy.

Authors:  S R Newcom; M E Kadin
Journal:  Lancet       Date:  1979-03-03       Impact factor: 79.321

9.  Immunoblastic lymphadenopathy with pulmonary infiltrates, hypocomplementemia and vasculitis. A hyperimmune syndrome.

Authors:  D Weisenburger; J Armitage; F Dick
Journal:  Am J Med       Date:  1977-12       Impact factor: 4.965

10.  Immunoblastic lymphadenopathy associated with methyldopa therapy: a case report.

Authors:  D D Weisenburger
Journal:  Cancer       Date:  1978-11       Impact factor: 6.860

View more
  1 in total

1.  Genetic changes in atypical hyperplasia and lymphoma with angioimmunoblastic lymphadenopathy and dysproteinaemia in the same patients.

Authors:  K Ohshima; M Kikuchi; M Hashimoto; M Kozuru; N Uike; S Kobari; Y Masuda; Y Sumiyoshi; S Yoneda; M Takeshita
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.